|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/517 | (2006.01) |
| A61K 31/00 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1948180 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06819380.4 |
| Date of filing the European patent application | 2006-11-09 | |
| (97) | Date of publication of the European application | 2008-07-30 |
| (45) | Date of publication and mention of the grant of the patent | 2013-03-13 |
| (46) | Date of publication of the claims translation | 2013-06-25 |
| (86) | Number | PCT/EP2006/068314 |
| Date | 2006-11-09 |
| (87) | Number | WO 2007/054551 |
| Date | 2007-05-18 |
| (30) | Number | Date | Country code |
| 05110669 | 2005-11-11 | EP |
| (72) |
SOLCA, Flavio, AT
AMELSBERG, Andree, US
STEHLE, Gerd, DE
VAN MEEL, Jacobus C., A., AT
BAUM, Anke, AT
|
| (73) |
Boehringer Ingelheim International GmbH,
Binger Strasse 173, 55216 Ingelheim am Rhein,
DE
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Sudėtinis vėžio gydymas, apimantis EGFR/HER2 inhibitorius |
| COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-10-27 | 20 | 347.00 EUR |